Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy (Q36327073)

13 August 2017

Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy (English)

1 reference

13 August 2017

Lorenzo Peverelli

1

0 references

Francesca Magri

Francesca Magri

7

0 references

Stefania Petrini

Stefania Petrini

5

0 references

Adele D'Amico

Adele D'Amico

4

0 references

Marina Mora

Marina Mora

9

0 references

Giacomo P Comi

Giacomo P Comi

13

0 references

Enrico Bertini

Enrico Bertini

11

0 references

Maurizio Moggio

14

Maurizio Moggio

1 reference

13 August 2017

12

Monica Sciacco

1 reference

13 August 2017

10

Tiziana Mongini

1 reference

13 August 2017

2

1 reference

13 August 2017

Luisa Villa

3

1 reference

13 August 2017

Chiara Favero

6

1 reference

13 August 2017

Lucia Morandi

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

23 October 2015

1 reference

13 August 2017

1 reference

13 August 2017

85

1 reference

13 August 2017

21

1 reference

13 August 2017

1886-1893

1 reference

describes a project that uses

13 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4662699/fullTextXML

inferred from PubMed Central ID database lookup

cites work

A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Epigenetic control of skeletal muscle regeneration: Integrating genetic determinants and environmental changes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Epigenetic regulation of skeletal muscle development and differentiation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Quantitative paraspinal muscle measurements: inter-software reliability and agreement using OsiriX and ImageJ

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Sculpting chromatin beyond the double helix: epigenetic control of skeletal myogenesis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Epigenetic regulation of satellite cell activation during muscle regeneration.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Systemic administration of PRO051 in Duchenne's muscular dystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

30 September 2017

ImageJ for microscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Eteplirsen for the treatment of Duchenne muscular dystrophy

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4662699

Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months

21 October 2018

1 reference

12 December 2020

Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands

1 reference

12 December 2020

Histopathological changes in Duchenne muscular dystrophy

1 reference

12 December 2020

Muscle histology in fetuses at risk for Duchenne muscular dystrophy

1 reference

12 December 2020

Short stature: a common feature in Duchenne muscular dystrophy

1 reference

12 December 2020

Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy

1 reference

12 December 2020

PCR and immunocytochemical analyses of dystrophin-positive fibers in Duchenne muscular dystrophy

1 reference

12 December 2020

Sarcoglycan deficiency in a large Italian population of myopathic patients

1 reference

12 December 2020

Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial

1 reference

12 December 2020

10.1212/WNL.0000000000002147

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

1 reference